Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart sensor could help Parkinson's patients move better

NCT ID NCT04176302

Symptom relief Sponsor: Consorci Sanitari de l'Alt Penedès i Garraf Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tested a wearable device called STAT-ON, which automatically records when Parkinson's patients have trouble moving ('Off' periods) and when they move well ('On' periods). The goal was to see if giving this detailed information to doctors helps them adjust medication more effectively than standard office visits or patient diaries. The study involved 173 people with moderate to severe Parkinson's disease who experience motor fluctuations.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Parkinson Holter (STAT-ON) wearable device
What this could lead to
If successful, this device could give doctors detailed, objective data on motor fluctuations, helping them fine-tune medication to reduce 'Off' periods and improve daily mobility.
What could go wrong
This is a completed trial with 173 participants, but the device is still a tool to aid decisions, not a treatment itself. It may not lead to better outcomes than standard care or patient diaries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

173 people

The number who actually took part.

Started

Nov 2019

Finished

Jun 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Ideopathic Parkinson's Disease * Disease in the moderate-severe phase (Hoehn \& Yahr ≥ 2 en Off) * Motor fluctuations (with at least 2h/day in Off) * Agree to participate voluntarily and will sign a written consent form Exclusion Criteria: * Incapable of walking independently or H\&Y=5 * Participating in another clinical trial * Patients with acute intercurrent disease * Psychiatric or cognitive disorders that prevent collaboration (MMSE \<24)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Parkinson disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Parkinson disease

Contacts and locations

Locations

  • Consorci Sanitari de Terrassa

    Terrassa, Spain

  • Consorci Sanitari de l'Alt Penedès i Garraf

    Vilafranca del Penedès, Barcelona, Spain

  • Consorci Sanitari del Maresme. Hospital de Mataró

    Mataró, Barcelona, Spain

  • Hospital Clínico San Carlos

    Madrid, Spain

  • Hospital Clínico Universitario de Valencia

    Valencia, Spain

  • Hospital General La Mancha-Centro, Alcázar de San Juan

    Alcázar de San Juan, Ciudad Real, Spain

  • Hospital General Parc Sanitari Sant Joan de Déu

    Sant Boi de Llobregat, Spain

  • Hospital General Universitario de Alicante

    Alicante, Spain

  • Hospital General de Elche

    Alicante, Spain

  • Hospital General de l'Hospitalet. CS Integral

    L'Hospitalet de Llobregat, Barcelona, Spain

  • Hospital Moisès Broggi - CS Integral

    Barcelona, Spain

  • Hospital Regional Universitario de Málaga

    Málaga, Spain

  • Hospital Royo de Vilanova

    Zaragoza, Spain

  • Hospital Sanitas CIMA

    Barcelona, Spain

  • Hospital Universitari General de Catalunya

    Sant Cugat del Vallès, Spain

  • Hospital Universitari Germans Trias i Pujol

    Badalona, Spain

  • Hospital Universitari Mútua Terrassa

    Terrassa, Barcelona, Spain

  • Hospital Universitari Vall d'Hebron

    Barcelona, Barcelona, Spain

  • Hospital Universitari dr. Josep Trueta

    Girona, Spain

  • Hospital Universitario 12 de Octubre

    Madrid, Madrid, Spain

  • Hospital Universitario Fundación Alcorcón

    Alcorcón, Madrid, Spain

  • Hospital Universitario Fundación Jiménez Díaz

    Madrid, Spain

  • Hospital Universitario Infanta Sofía

    San Sebastián de los Reyes, Spain

  • Hospital Universitario Juan Ramón Jiménez

    Huelva, Spain

  • Hospital Universitario La Moraleja

    Madrid, Spain

  • Hospital Universitario La Princesa

    Madrid, Madrid, Spain

  • Hospital Universitario Lucus Augustí

    Lugo, Galicia, Spain

  • Hospital Universitario Marqués de Valdecilla

    Santander, Cantabria, Spain

  • Hospital Universitario Puerta de Hierro, Majadahonda

    Majadahonda, Madrid, Spain

  • Hospital Universitario Ramón y Cajal

    Madrid, Madrid, Spain

  • Hospital Universitario Virgen de la Victoria

    Málaga, Spain

  • Hospital Universitario Virgen del Rocío

    Seville, Spain

  • Hospital Universitario de Burgos

    Burgos, Spain

  • Hospital Universitario de Donostia

    Donostia / San Sebastian, Guipúzkoa, Spain

  • Hospital Universitario del Henares

    Madrid, Madrid, Spain

  • Hospital Univesitario Virgen de la Arrixaca

    El Palmar, Murcia, Spain

  • Hospital Verge de la Cinta

    Tortosa, Tarragona, Spain

  • Hospital Virgen de la Salud

    Toledo, Spain

  • Hospital de Llíria

    Valencia, Spain

  • Hospital de la Santa Creu i Sant Pau

    Barcelona, Barcelona, Spain

  • Hospital del Mar

    Barcelona, Barcelona, Spain

  • Hospital Álvaro Cunqueiro

    Vigo, Pontevedra, Spain

  • Terapia Integral UParkinson, SL

    Barcelona, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.